New research reveals a statistical technique used in Alzheimer's drug trials inflates clinical efficacy claims by 29x.
Objectives To evaluate the performance of large language models (LLMs) in risk of bias assessment and to examine whether ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results